Log in or Sign up for Free to view tailored content for your specialty!
Sarcoma News
NCCN Foundation presents awards to young investigators
Six early-career investigators received NCCN Foundation Young Investigator Awards.
Adolescents and young adults with cancer require dedicated services, research
Going through cancer during transitional adolescent and young adult years can present additional social, financial and mental health challenges that add to the stressors of diagnosis and treatment.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants fast track designation to annamycin for sarcoma lung metastases
The FDA granted fast track designation to annamycin for the treatment of patients with lung metastases from soft tissue sarcoma, according to a press release from the agent’s manufacturer.
Sarcoma Alliance appoints board member
Sarcoma Alliance appointed William Tseng, MD, to its board of directors.
FDA grants orphan drug designation to annamycin for soft tissue sarcoma
The FDA granted orphan drug designation to annamycin for the treatment of patients with soft tissue sarcoma, according to a manufacturer-issued press release.
Ipilimumab-nivolumab combination effective, safe for angiosarcoma subset
A quarter of patients with unresectable or metastatic angiosarcoma responded to a combination of ipilimumab and nivolumab, according to results of an analysis presented at the virtual Society for Immunotherapy of Cancer Annual Meeting.
FDA grants regulatory designations to PTC596 for sarcoma, glioma subsets
The FDA granted fast track and orphan drug designations to PTC596 for treatment of leiomyosarcoma, according to the agent’s manufacturer.
Letetresgene autoleucel safe, active in advanced synovial sarcoma
Letetresgene autoleucel demonstrated clinical activity among patients with advanced synovial sarcoma, according to final phase 1 study results presented at the virtual Society for Immunotherapy of Cancer Annual Meeting.
Letetresgene autoleucel safe, active in advanced synovial sarcoma
Letetresgene autoleucel demonstrated clinical activity among patients with advanced synovial sarcoma, according to final phase 1 study results presented at the virtual Society for Immunotherapy of Cancer Annual Meeting.
Cancer led to 4 million potential years of life lost in 2017
Cancer led to 4 million potential years of life lost in 2017 in the United States, with cancers occurring in younger patients accounting for a disproportionate amount of the burden, according to study results.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read